Filing Details
- Accession Number:
- 0001209191-21-067658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-02 17:12:07
- Reporting Period:
- 2021-12-01
- Accepted Time:
- 2021-12-02 17:12:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1741830 | Kronos Bio Inc. | KRON | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1797819 | Marianne Backer De | C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 400 San Mateo CA 94402 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-01 | 1,150 | $11.57 | 2,750 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $11.57, and the range of prices were between $11.38 and $11.79. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.